Future Science Group launches Clinical Investigation journal

16 Dec 2010

Your browser does not support inline frames or is currently configured not to display inline frames. In recognition of the methodology, progress and outcome of clinical trials, Future Science has announced the launch of the definitive title Clinical Investigation.

The journal is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials. As a peer-reviewed, monthly publication Clinical Investigation provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase I trials through to post-marketing studies and pharmacoeconomic research.

Clinical Investigation assimilates the wealth of information resulting from the clinical development of new medicines into concise yet comprehensive formats. The journal addresses contemporary issues in clinical drug development and methodology, and also provides a platform for the rapid publication of new drug data from human studies.

Coverage spans all therapeutic areas and relates to conventional small-molecule drugs as well as biotech-derived therapeutic entities, including vaccines, monoclonal antibodies, antisense, cell and gene therapies and recombinant proteins. The journal publishes review articles, original papers, perspectives, commentaries, meeting reports, news, views and more.

Clinical Investigation provides a systematic program of peer-reviewed coverage relating to the clinical evaluation of new and established therapies. The audience for Clinical Investigation includes clinical investigators, healthcare decision makers, formulary managers, clinicians, regulatory personnel and medical affairs professionals.

Prof. E. Michael Lewiecki, Senior Editor, is responsible for the editorial direction of Clinical Investigation, and supported by a team of Associate Editors and experts making up the international Editorial Advisory board.

Senior Editor Lewiecki commented, “Clinical Investigation is an excellent addition to the Future Science journal collection, Clinical Investigation fulfils an unmet need in providing critical review of objectives and outcomes of clinical trials."

	Future Science Group launches Clinical Investigation journal 16 Dec 2010 Your browser does not support inline frames or is currently configured not to display inline frames. In recognition of the methodology, progress and outcome of clinical trials, Future Science has announced the launch of the definitive title Clinical Investigation. The journal is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials. As a peer-reviewed, monthly publication Clinical Investigation provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase I trials through to post-marketing studies and pharmacoeconomic research. Clinical Investigation assimilates the wealth of information resulting from the clinical development of new medicines into concise yet comprehensive formats. The journal addresses contemporary issues in clinical drug development and methodology, and also provides a platform for the rapid publication of new drug data from human studies. Coverage spans all therapeutic areas and relates to conventional small-molecule drugs as well as biotech-derived therapeutic entities, including vaccines, monoclonal antibodies, antisense, cell and gene therapies and recombinant proteins. The journal publishes review articles, original papers, perspectives, commentaries, meeting reports, news, views and more. Clinical Investigation provides a systematic program of peer-reviewed coverage relating to the clinical evaluation of new and established therapies. The audience for Clinical Investigation includes clinical investigators, healthcare decision makers, formulary managers, clinicians, regulatory personnel and medical affairs professionals. Prof. E. Michael Lewiecki, Senior Editor, is responsible for the editorial direction of Clinical Investigation, and supported by a team of Associate Editors and experts making up the international Editorial Advisory board. Senior Editor Lewiecki commented, “Clinical Investigation is an excellent addition to the Future Science journal collection, Clinical Investigation fulfils an unmet need in providing critical review of objectives and outcomes of clinical trials." To top